A neutralizing monoclonal antibody to the IL-6 receptor preserved kidney function and structure of glomeruli in a mouse model of nephritis, indicating therapeutic potential for targeting IL-6 signaling alone in CKD [70]. The gene discussed is IL6; the disease is chronic kidney disease.